Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):409–415. doi: 10.1158/1055-9965.EPI-13-0738

Table 3.

Associations between biomarkers of interest and state of residency

Biomarker Alaska (N=42) Arizona (N=53) P-value4
Continuous Markers1
P53 40.3 (38.8) 18.5 (31.1) 0.004
MIB-1 21.6 (21.8) 27.7 (22.5) 0.190
Cyclin D1 21.5 (28.0) 25.3 (22.7) 0.476
Ordinal Markers2
EGFR 0.15 (0.58) 0.53 (0.82) 0.015
BCL-2 2.07 (1.30) 2.17 (1.07) 0.686
HER2 0.81 (1.13) 1.32 (1.01) 0.023
Binary Markers3
ER 0.722
 Negative 9 (21) 13 (25)
 Positive 33 (79) 40 (75)
PR 0.095
 Negative 12 (29) 24 (45)
 Positive 30 (71) 29 (55)
HER2 (2 or 3+) 0.087
 Negative 33 (79) 33 (62)
 Positive 9 (21) 20 (38)
HER2 (3+) 0.968
 Negative 35 (83) 44 (83)
 Positive 7 (17) 9 (17)
ER/PR/HER2 (2 or 3+) 0.930
 Triple Negative 5 (12) 6 (11)
 Positive 37 (88) 47 (89)
ER/PR/HER2 (3+) 0.849
 Triple Negative 5 (12) 7 (13)
 Positive 37 (88) 46 (87)
1

Values for continuous markers are based on percent staining and range from 0 to 100. Summary statistics provided are mean (standard deviation).

2

Values for ordinal markers are based on staining intensity and take on values of 0, 1, 2, or 3. Summary statistics provided are mean (standard deviation).

3

Binary markers are classified as negative or positive. Summary statistics provided are Number positive (percent).

4

Unadjusted p-value from two-sample t-test (for continuous or ordinal markers) or chi-square test (for binary markers). Age-adjusted analyses and randomization tests yielded similar results.